Spatial Genomics

About:

Spatial Genomics is a developer of sequential fluorescence in situ hybridization (seqFISH) technology.

Website: https://spatialgenomics.com/

Top Investors: Fulgent Therapeutics, 12 West Capital

Description:

Spatial Genomics is an innovative leaders in the field of spatial analysis, we are dedicated to empowering discovery.We believe that Spatial Genomics will become a standard research tool used routinely by labs worldwide.

Total Funding Amount:

$56M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Pasadena, California, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)spatialgenomics.com

Founders:

Drew Kennedy, Kirsten Frieda

Number of Employees:

11-50

Last Funding Date:

2022-02-23

IPO Status:

Private

Industries: